Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma
Autore:
Balch, CM; Buzaid, AC; Soong, SJ; Atkins, MB; Cascinelli, N; Coit, DG; Fleming, ID; Gershenwald, JE; Houghton, A; Kirkwood, JM; McMasters, KM; Mihm, MF; Morton, DL; Reintgen, DS; Ross, MI; Sober, A; Thompson, JA; Thompson, JF;
Indirizzi:
Johns Hopkins Med Inst, Baltimore, MD 21205 USA Johns Hopkins Med Inst Baltimore MD USA 21205 st, Baltimore, MD 21205 USA Amer Soc Clin Oncol, Alexandria, VA 22314 USA Amer Soc Clin Oncol Alexandria VA USA 22314 col, Alexandria, VA 22314 USA Hosp Sirio Libanes, Sao Paulo, Brazil Hosp Sirio Libanes Sao Paulo Brazil sp Sirio Libanes, Sao Paulo, Brazil Univ Alabama, Birmingham, AL USA Univ Alabama Birmingham AL USAUniv Alabama, Birmingham, AL USA Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA Beth Israel Deaconess Med Ctr Boston MA USA 02215 r, Boston, MA 02215 USA Massachusetts Gen Hosp, Boston, MA 02114 USA Massachusetts Gen Hosp Boston MA USA 02114 Gen Hosp, Boston, MA 02114 USA WHO, Melanoma Program, Milan, Italy WHO Milan ItalyWHO, Melanoma Program, Milan, Italy Ist Nazl Tumori, I-20133 Milan, Italy Ist Nazl Tumori Milan Italy I-20133 st Nazl Tumori, I-20133 Milan, Italy Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr New York NY USA 10021 New York, NY 10021 USA Methodist Hosp, Ctr Canc, Memphis, TN USA Methodist Hosp Memphis TN USAMethodist Hosp, Ctr Canc, Memphis, TN USA Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas Houston TX USA 77030 Anderson Canc Ctr, Houston, TX 77030 USA Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA Univ Pittsburgh Pittsburgh PA USA ittsburgh, Med Ctr, Pittsburgh, PA USA Univ Louisville, Med Ctr, Louisville, KY 40292 USA Univ Louisville Louisville KY USA 40292 Med Ctr, Louisville, KY 40292 USA John Wayne Canc Inst, Santa Monica, CA USA John Wayne Canc Inst Santa Monica CA USA Canc Inst, Santa Monica, CA USA Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA Univ S Florida Tampa FL USA 33682 e Moffitt Canc Ctr, Tampa, FL 33682 USA Univ Washington, Med Ctr, Seattle, WA 98195 USA Univ Washington Seattle WA USA 98195 gton, Med Ctr, Seattle, WA 98195 USA Univ Sydney, Sydney Melanoma Unit, Sydney, NSW 2006, Australia Univ Sydney Sydney NSW Australia 2006 a Unit, Sydney, NSW 2006, Australia
Titolo Testata:
JOURNAL OF CLINICAL ONCOLOGY
fascicolo: 16, volume: 19, anno: 2001,
pagine: 3635 - 3648
SICI:
0732-183X(20010815)19:16<3635:FVOTAJ>2.0.ZU;2-X
Fonte:
ISI
Lingua:
ENG
Soggetto:
LYMPH-NODE BIOPSY; METASTATIC MALIGNANT-MELANOMA; MM PRIMARY MELANOMA; PROGNOSTIC FACTORS; SENTINEL LYMPHADENECTOMY; I MELANOMA; LONG-TERM; MULTIFACTORIAL ANALYSIS; MICROSCOPIC SATELLITES; LACTATE-DEHYDROGENASE;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
83
Recensione:
Indirizzi per estratti:
Indirizzo: Balch, CM Amer Soc Clin Oncol, 1900 Duke St,Ste 200, Alexandria, VA 22314 USA Amer Soc Clin Oncol 1900 Duke St,Ste 200 Alexandria VA USA 22314
Citazione:
C.M. Balch et al., "Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma", J CL ONCOL, 19(16), 2001, pp. 3635-3648

Abstract

Purpose: To revise the staging system for cutaneous melanoma under the auspices of the American Joint Committee on Cancer (AJCC). Materials and Methods: The prognostic factors analysis described in the companion publication (this issue), as well as evidence from the published literature, was used to assemble the tumor-node-metastasis criteria and stagegrouping for the melanoma staging system. Results: Major changes include (1) melanoma thickness and ulceration but not level of invasion to be used in the T category (except for T1 melanomas); (2) the number of metastatic lymph nodes rather than their gross dimensions and the delineation of clinically occult (ie, microscopic) versus clinically apparent (ie, macroscopic) nodal metastases to be used in the N category; (3) the site of distant metastases and the presence of elevated serum lactic dehydrogenase to be used in the M category; (4) an upstaging of all patients with stage I, II, and III disease when a primary melanoma is ulcerated; (5) a merging of satellite metastases around a primary melanoma and in-transit metastases into a single staging entity that is grouped into stageIII disease; and (6) a new convention for defining clinical and pathologicstaging so as to take into account the staging information gained from intraoperative lymphatic mapping and sentinel node biopsy. Conclusion: This revision will become official with publication of the sixth edition of the AJCC Cancer Staging Manual in the year 2002. J Clin Oncol 19:3635-3648. (C) 2001 by American Society of Clinical Oncology.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/12/20 alle ore 16:15:23